Myocardial ischemia from dibutylone use

Authors

  • Antonio Pascale Hospital Británico, Departamento de Emergencia, Profesor adjunto de Toxicología. , Médico toxicólogo
  • Eleuterio Umpierrez Universidad de la República, Facultad de Química. Instituto Polo Tecnológico de Pando, Unidad de Medio Ambiente, Drogas y Doping. Profesor adjunto de Química
  • Jorge Menoni Hospital Británico, Departamento de Emergencia, Profesor adjunto de Clínica Médica 1, Médico internista
  • Virginia Collazzi Hospital Británico, Departamento de Emergencia, Médica cardióloga
  • Virginia Rodríguez Hospital Británico, Departamento de Emergencia, Asistente de Clínica Médica 1, Médica internista

DOI:

https://doi.org/10.29193/RMU.36.4.14

Keywords:

MYOCARDIAL ISCHEMIA, DESIGNER DRUGS, CATHINONE, DIBUTYLONE, POISONING

Abstract

Synthetic cathinone are stimulating synthetic drugs used for recreational purposes on their own or as adulterants in cocaine and amphetamines derivatives that are traded in illegal markets given their stimulating and disturbing properties on the central nervous system.

Globally, there is a growing number of acute intoxications and complications as a consequence of consumption of these substances. In Uruguay they were first detected in 2015, there being limited epidemiological data. Synthetic cathinone are not detected by the immunochromatographic tests available at the laboratories of the emergency services in our country. The study describes the first case of intoxication by a synthetic cathinone (dibutylone) in Uruugay, in a 45 year old patient as a result of powder sold as “ecstasy”. The patient presented an acute coronary syndrome, subsequent evolution being good. Diagnostic confirmation was made in urine using   gas chromatography coupled with mass spectrometry. The chemical structure of dibutylone and its action mechanism explain the clinical manifestations and the coronary vasospasm causing ischemia. When there is no clear sign of a patient having been exposed to this substance and upon the current epidemiological state, the presence of clinical symptoms that are compatible with a stimulating drug and a negative result for cocaine and amphetamines in immunochromatographic tests must lead us to be suspicious about the presence of synthetic stimulating substances as cathinone, as in the case studied.

References

(1) Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 2012; 8:33-42.
(2) Nelson ME, Bryant SM, Aks SE. Emerging drugs of abuse. Emerg Med Clin North Am 2014; 32:1-28.
(3) Baumann MH, Solis E Jr, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL. Baths salts, spice, and related designer drugs: the science behind the headlines. J Neurosci 2014; 34(46):15150-8.
(4) United Nations Office on Drugs Crime. Laboratory and Scientific Section Portals. Synthetic cathinones. Disponible en: https://www.unodc.org/LSS/SubstanceGroup/Details/67b1ba69-1253-4ae9-bd93-fed1ae8e6802 [Consulta: 31 mayo 2020].
(5) Banks ML, Worst TJ, Rusyniak DE, Sprague JE. Synthetic cathinones (“bath salts”). J Emerg Med 2014; 46(5):632-42.
(6) Oliver CF, Palamar JJ, Salomone A, Simmons SJ, Philogene- Khalid H, Stokes-McCloskey N, et al. Synthetic cathinone adulteration of illegal drugs. Psychopharmacology (Berl) 2019; 236(3):869-79.
(7) Derungs A, Schietzel S, Meyer MR, Maurer HH, Krähenbühl S, Liechti ME. Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone). Clin Toxicol (Phila) 2011; 49(7): 691-3.
(8) Krotulski AJ, Mohr AL, Papsun DM, Logan BK. Dibutylone (bk-DMBDB): intoxications, quantitative confirmations and metabolism in authentic biological specimens. J Anal Toxicol 2018; 42(7):437-45.
(9) Warrick BJ, Wilson J, Hedge M, Freeman S, Leonard K, Aaron C. Lethal serotonin syndrome after methylone and butylone ingestion. J Med Toxicol 2012; 8:65-8.
(10) Rojek S, K³ys M, Strona M, Maciów M, Kula K. “Legal highs”—toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration. Forensic Sci Int 2012; 222(1-3):e1-6.
(11) Zaitsu K, Katagi M, Kamata HT, Kamata T, Shima N, Miki A, et al. Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine. Forensic Sci Int 2009; 188(1-3):131-9.
(12) Observatorio de Drogas de Colombia. Detección de nueva catinona sintética: comprimidos en forma de Hello Kitty con contenido de butilona. Agosto 2017. Disponible: http://www.cicad.oas.org/oid/sata/colombia/SAT_sobre_Drogas_de_Colombia_alerta_butilona.pdf [Consulta: 15 agosto 2018].
(13) Junta Nacional de Drogas. Observatorio Uruguayo de Drogas; Umpierrez E. Screening de nuevas sustancias psicoactivas y cocaína en muestras de orina en fiestas electrónicas en Uruguay. 2016. Disponible en: https://www.gub.uy/ junta-nacional-drogas/comunicacion/publicaciones/screening-nuevas-sustancias-psicoactivas-cocaina-muestras-orina-fiestas [Consulta: 31 mayo 2020].
(14) Junta Nacional de Drogas. Observatorio Uruguayo de Drogas; Umpierrez E. Informe Final: screening de nuevas sustancias psicoactivas, THC y cocaiìna en muestras de orina obtenidas en una fiesta musical en el aìrea metropolitana. 2017. Disponible en https://www.gub.uy/junta-nacional-drogas/comunicacion/publicaciones/nuevas-sustancias-psicoactivas-otras-drogas-abuso-consumidas-fiestas [Consulta: 31 mayo 2020].
(15) Krotulski AJ, Mohr AL, Fogarty MF, Logan BK. The detection of novel stimulants in oral fluid from users reporting ecstasy, molly and MDMA ingestion. J Anal Toxicol 2018; 42(8):544-53.
(16) Simmler LD, TA Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, et al. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 2013; 168:458-70.
(17) Burillo-Putze G, Díaz BC, Pazos JL, Mas PM, Miroì O, Puiguriguer P, et al. Drogas emergentes (I): smart drugs. An Sist Sanit Navar 2011; 34(2):263-74.
(18) Kloner RA, Mitchell M, Emmick JT. Cardiovascular effects of tadalafil. Am J Cardiol 2003; 92(9A):37M-46M.
(19) Papaseit E, Pérez-Mañá C, de Sousa Fernandes Perna EB, Olesti E, Mateus J, Kuypers KP, et al. Mephedrone and alcohol interactions in humans. Front Pharmacol 2020; 10:1588.

Published

2020-12-01

How to Cite

1.
Pascale A, Umpierrez E, Menoni J, Collazzi V, Rodríguez V. Myocardial ischemia from dibutylone use. Rev. Méd. Urug. [Internet]. 2020 Dec. 1 [cited 2024 Sep. 16];36(4):449-54. Available from: https://revista.rmu.org.uy/index.php/rmu/article/view/652

Most read articles by the same author(s)